Navigation Links
Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
Date:1/7/2008

apan the same innovative therapy that is already available to patients in the U.S. and Europe," said Dr. Yuzuru Kanakura, M.D. Ph.D., Professor and Chairman Department of Hematology and Oncology, Osaka University Graduate School of Medicine. "We are excited to be participating in such an important study and look forward to the Soliris program progressing to registration in Japan."

"After consultation with the leading PNH clinical investigators in Japan and with the PMDA, we are pleased to have commenced dosing with Soliris in the AEGIS study, our single Japanese registration trial," said Leonard Bell, M.D., Chief Executive Officer of Alexion. "After completing enrollment and dosing, and comparing these results in Japanese patients to our earlier PNH studies, we expect to submit a licensing application for Soliris in PNH to the Japanese regulatory authority. Initiating this Japanese registration study is an important component of reaching our global goal that every PNH patient who can benefit from Soliris will have access to it."

About PNH

PNH is a rare blood disease that affects an estimated 8,000 to 10,000 people in North America and Europe and, using similar prevalence estimates, potentially 1,000 - 2,000 patients in Japan. (3) PNH often strikes people in the prime of their lives, with an average age of onset in the early 30's. (4) Approximately ten percent of all patients first develop symptoms at 21 years of age or younger. (5) PNH develops without warning and can occur in men and women of all races, backgrounds and ages. PNH often goes unrecognized, with delays in diagnosis often ranging from one to more than 10 years. (6) The estimated median survival for PNH patients is between 10 and 15 years from the time of diagnosis. (4,6)

PNH has been identified more commonly among patients with disorders of the bone marrow, including aplastic anemia (AA) and myelodysplastic syndrome (MDS). (7,8,9,10) In patients with thrombosis of unknown ori
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
2. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
3. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
4. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
5. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
6. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
10. MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule
11. VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... -- Among 1,000 U.S. consumers, the majority (65.3 percent) ... surveyed are aware of prescription savings cards, and just ... to findings from a new survey released today by ... improving the health and well-being of individuals, families and ... and women, ages 21 and older, on their spending, ...
(Date:8/4/2015)... 4, 2015  Ironshore Pharmaceuticals & Development, Inc. ... a company specializing in personalized medicine, to participate ... designed to evaluate the safety and efficacy of ... Attention-deficit/hyperactivity disorder (ADHD). This is Restore,s second clinical ... originally partnered with Ironshore in 2014 and continues ...
(Date:8/3/2015)...  Landauer, Inc. (NYSE: LDR ), a recognized ... outsourced medical physics services and high quality medical consumable ... the fiscal third quarter 2015 after the market close ... Company will also host a conference call for investors ... Time (10:00 a.m. Eastern Time). Investors may access the ...
Breaking Medicine Technology:New Study Finds Consumers are Leaving Money at the Pharmacy 2New Study Finds Consumers are Leaving Money at the Pharmacy 3Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Third Quarter 2015 Results And Conference Call 2
... Schering-Plough,Corporation (NYSE: SGP ) and The ... of Baltimore today announced results of the ... Eptifibatide to,Arrest the Reactivity of Platelets) study, ... IIIa inhibitor, significantly inhibited,platelet aggregation when added ...
... Immtech Pharmaceuticals,Inc. (Amex: IMM ) today ... a,scientific consortium led by the University of North ... The Bill & Melinda Gates Foundation,(the "Gates Foundation"), ... and leishmania. This grant is part of the ...
Cached Medicine Technology:Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 2Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 3Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 4Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 5Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 2Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 3
(Date:8/4/2015)... , ... August 04, 2015 , ... ... manufacturing, label design, product packaging, and fulfillment services, joined over 200 other Long ... event was held on Tuesday, July 28th at Jones Beach State Park in ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... complete with full examination now offered by the world renowned Beverly Hills ... aesthetic facial appearance through cosmetic surgery techniques helps individuals to achieve an outer ...
(Date:8/4/2015)... ... August 04, 2015 , ... Montclair State University and Atlantic Health System ... its kind in New Jersey, which starting this Fall will help prepare those entering ... partnered with Atlantic Health System, one of the largest health care organizations in New ...
(Date:8/4/2015)... Denver, CO (PRWEB) , ... August 04, 2015 ... ... for skilled nursing homes and other long-term care facilities, today announced details of ... (QAPI) for nursing homes and centers. , Providigm’s QAPI Accreditation program , ...
(Date:8/4/2015)... ... August 04, 2015 , ... Sin City Gallery is delighted ... a diverse group of exceptionally talented female artists. The exhibition premieres at ... September 25-27, 2015 in Downtown Las Vegas. Curated by gallery director Dr. Laura ...
Breaking Medicine News(10 mins):Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 2Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 3Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 2Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 4
... March 12 Jordan Lapides, a 54-year-old teacher of Spirituality ... And Spiritual Development in Pennsylvania, was recently challenged by one ... his weight problem. Lapides took up the challenge and ... has sparked a media frenzy. He has appeared on television, ...
... the counter treatment for,chronic and acute wounds. The revolutionary new product ... prevents scar formation. , ... Bellwood, IL (PRWEB) March ... on revolutionary technology in the healing of wounds. Based on a ...
... deployed as the electronic data capture and clinical data management system ... , ... New Haven, CT (PRWEB) March 12, 2009 ... the OpenClinica clinical data capture and management software for the Parkinson,s ...
... Colon(R) Educational Exhibit to Detroit Science Center, March 13 ... March 11 Colorectal cancer (cancer that begins either ... common cancer in both men and women in the ... 148,810 Americans were diagnosed with colorectal cancer in 2008, ...
... begin with one altruistic living donor, study explains, , , ... healthy young man stepped forward, willing to give one ... later, 10 people had received new kidneys from that ... started the first nonsimultaneous, extended altruistic-donor (NEAD) chain. The ...
... Salmonella bacteria research from two recent NASA ... bacteria,s disease-causing potential that hold promise for ... Earth.(Logo: http://www.newscom.com/cgi-bin/prnh/20081007/38461LOGO )Salmonella is ... related illnesses. According to the Centers for ...
Cached Medicine News:Health News:54-Year-Old Psychology Teacher Loses 155 Pounds In 10 Months By Applying His Own Teachings To Himself 2Health News:Wound Be Gone: Quickly Gaining Strong Support from Clinician Experts in the Field of Wound Healing 2Health News:Institute for Neurodegenerative Disorders Deploys OpenClinica EDC solution for Large Parkinson's Study 2Health News:Institute for Neurodegenerative Disorders Deploys OpenClinica EDC solution for Large Parkinson's Study 3Health News:Keep Your Rear in the Clear 2Health News:Keep Your Rear in the Clear 3Health News:Keep Your Rear in the Clear 4Health News:Living Kidney Donation Chains May Help More Get Transplants 2Health News:Living Kidney Donation Chains May Help More Get Transplants 3Health News:Space Research May Help Explain Salmonella Illness 2Health News:Space Research May Help Explain Salmonella Illness 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: